CD274 and cancer: Structural alterations leading to the disruption of the 3′ UTR of the PD-L1 gene have been recently described [97] and appear to be highly common in different cancer types including T cell leukemia/lymphoma, diffuse large B cell lymphoma and stomach adenocarcinoma.